InspireMD names James Barry as president and CEO
Prior to this appointment, Dr. Barry served as InspireMD’s Chief Operating Officer since July 2014 and has been a member of the Company’s Board of Directors since January 2012.
Dr. Barry brings more than two decades of experience in the medical device industry. For more than 18 years, he held senior roles at Boston Scientific Corporation. Dr. Barry initiated and oversaw the development of Boston Scientific’s Taxus stent. He also oversaw the development of the technology that is employed in the Synergy Everolimus-Eluting Stent System.
In addition to serving as a Board Member of InspireMD, Dr. Barry serves on a number of Advisory Boards including the College of Biomedical Engineering at Yale University, the College of Sciences at University of Massachusetts-Lowell, and the Massachusetts Life Science Center.
Dr. Barry holds a Bachelor’s Degree in Chemistry from St. Anselm College and a Ph.D. in Biochemistry from the University of Massachusetts-Lowell.
He replaces Alan Milinazzo, who previously announced his decision to step down as Director, President and CEO in January 2016.
Mr. Milinazzo will continue to serve as an advisor to the Company. ■
LATEST MOVES FROM Massachusetts
- RXi Pharmaceuticals appoints Jonathan Freeman as director
- Corero promotes Andrew Lloyd to executive role
- AMAG Pharmaceuticals appoints Brian Kelley to board
- Visal Leng named president and CEO, Asia Pacific, GE Oil & Gas
- Veristat appoints James Roach as chief medical officer
More inside POST
Kroger Q1 net earnings $303 million Earnings
ReneSola Q1 revenue $156.6 million Earnings